CVS vs DGX
As of Sep 20, 2026, CVS HEALTH (CVS) scores 4.5/10 and Quest Diagnostics (DGX) 6.8/10 on AlphaStocks' five-model composite, so DGX scores higher. CVS trades 78% above its model fair value; DGX trades 24% above its model fair value.
CVS
CVS HEALTH Corp
4.5
Weak
$88.85
DGX
QUEST DIAGNOSTICS INC
6.8
Consider Buy
$246.52
CVS vs DGX: Which is the Better Investment?
CVS HEALTH Corp (CVS) scores 4.5/10 while QUEST DIAGNOSTICS INC (DGX) scores 6.8/10 on AlphaStocks' composite model. QUEST DIAGNOSTICS INC has the higher composite rating of Consider Buy. On a P/E basis, QUEST DIAGNOSTICS INC trades at 28.1x, making it the more attractively priced of the two.
This comparison is algorithmically generated and is not financial advice.
| Metric | CVS | DGX |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 4.5/10 | 6.8/10▲ |
| Rating | Weak | Consider Buy▲ |
| Price | $88.85 | $246.52 |
| P/E Ratio | 63.9 | 28.1▲ |
| ROE | 2.4% | 13.8%▲ |
| Market Cap | $114B | $28B |
| Fair Value | $50.03 | $199.57 |
| Dividend Yield | 2.6%▲ | 1.5% |
| Sector Rank | #128 of 168 | #19 of 168▲ |
| Model Verdicts | ||
| Piotroski | Attractive | Strong▲ |
| Buffett | Caution | Attractive▲ |
| Graham | Caution | Caution |
| Lynch | Caution | Neutral▲ |
| Greenblatt | Caution | Attractive▲ |
Related comparisons
CVS vs DGX: Which Stock Scores Higher?
CVS HEALTH Corp (CVS) and QUEST DIAGNOSTICS INC (DGX) are both in the Health Care sector. DGX currently leads with a composite score of 6.8/10 (Consider Buy) compared to CVS's 4.5/10 (Weak).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer